NasdaqCM - Delayed Quote USD

Mangoceuticals, Inc. (MGRX)

0.2631 -0.0169 (-6.04%)
At close: April 26 at 4:00 PM EDT
0.2815 +0.02 (+6.99%)
After hours: April 26 at 7:32 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
Total Revenue
731.4930
731.4930
8.9390
Cost of Revenue
299.9920
299.9920
4.0890
Gross Profit
431.5010
431.5010
4.8500
Operating Expense
9,650.3910
9,650.3910
1,996.4320
Operating Income
-9,218.8900
-9,218.8900
-1,991.5820
Net Non Operating Interest Income Expense
--
--
-6.4730
Other Income Expense
6.4730
6.4730
--
Pretax Income
-9,212.4170
-9,212.4170
-1,998.0550
Net Income Common Stockholders
-9,212.4170
-9,212.4170
-1,998.0550
Diluted NI Available to Com Stockholders
-9,212.4170
-9,212.4170
-1,998.0550
Basic EPS
-0.57
--
-0.13
Diluted EPS
-0.57
--
-0.13
Basic Average Shares
16,113.0290
--
15,315.0000
Diluted Average Shares
16,113.0290
--
15,315.0000
Total Operating Income as Reported
-9,218.8900
-9,218.8900
-1,991.5820
Total Expenses
9,950.3830
9,950.3830
2,000.5210
Net Income from Continuing & Discontinued Operation
-9,212.4170
-9,212.4170
-1,998.0550
Normalized Income
-9,212.4170
-9,212.4170
-1,998.0550
Interest Expense
--
--
6.4730
Net Interest Income
--
--
-6.4730
EBIT
-9,212.4170
-9,212.4170
-1,991.5820
EBITDA
-9,187.5280
-9,187.5280
-1,987.7190
Reconciled Cost of Revenue
299.9920
299.9920
4.0890
Reconciled Depreciation
24.8890
24.8890
3.8630
Net Income from Continuing Operation Net Minority Interest
-9,212.4170
-9,212.4170
-1,998.0550
Normalized EBITDA
-9,187.5280
-9,187.5280
-1,987.7190
12/31/2022 - 3/21/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers